J. Barratt Et Al. , "WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL," KIDNEY INTERNATIONAL REPORTS , vol.9, no.4, pp.174-175, 2024
Barratt, J. Et Al. 2024. WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL. KIDNEY INTERNATIONAL REPORTS , vol.9, no.4 , 174-175.
Barratt, J., Kristensen, J., Stone, A., Floege, J., Tesař, V., Trimarchi, H., ... Zhang, H.(2024). WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL. KIDNEY INTERNATIONAL REPORTS , vol.9, no.4, 174-175.
Barratt, Jonathan Et Al. "WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL," KIDNEY INTERNATIONAL REPORTS , vol.9, no.4, 174-175, 2024
Barratt, Jonathan Et Al. "WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL." KIDNEY INTERNATIONAL REPORTS , vol.9, no.4, pp.174-175, 2024
Barratt, J. Et Al. (2024) . "WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL." KIDNEY INTERNATIONAL REPORTS , vol.9, no.4, pp.174-175.
@article{article, author={Jonathan Barratt Et Al. }, title={WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL}, journal={KIDNEY INTERNATIONAL REPORTS}, year=2024, pages={174-175} }